CVR number 34083738
Industry 72.1900 Other research and experimental development on natural sciences and engineering

ACESION PHARMA ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmarkIFRS
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Bankruptcy risk for industry  1.1% 1.1% 1.1% 1.1% 1.1%  
Bankruptcy risk  0.0% 0.0% 7.1% 13.1% 12.4%  
Credit score (0-100)  0 0 37 20 20  
Credit rating  N/A N/A BBB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 -0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 -14,394 -17,451 -18,918  
EBITDA  0.0 0.0 -22,608 -29,199 -30,438  
EBIT  0.0 0.0 -22,821 -29,414 -30,542  
Pre-tax profit (PTP)  0.0 0.0 -22,818.6 -29,472.5 -30,588.4  
Net earnings  0.0 0.0 -18,262.3 -23,972.5 -25,088.4  
Pre-tax profit without non-rec. items  0.0 0.0 -22,819 -29,472 -30,588  
 
See the entire income statement

Balance sheet (kDKK) 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Tangible assets total  0.0 0.0 350 135 31.4  
Shareholders equity total  0.0 0.0 14,054 -9,918 -6,496  
Interest-bearing liabilities  0.0 0.0 19,917 26,516 30,664  
Balance sheet total (assets)  0.0 0.0 39,786 22,817 29,379  
Net Debt  0.0 0.0 -13,752 10,716 7,636  
 
See the entire balance sheet

Volume 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 -14,394 -17,451 -18,918  
Gross profit growth  0.0% 0.0% 0.0% -21.2% -8.4%  
Employees  0 0 10 10 10  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 39,786 22,817 29,379  
Balance sheet change%  0.0% 0.0% 0.0% -42.7% 28.8%  
Added value  0.0 0.0 -22,607.6 -29,200.4 -30,437.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 137 -430 -207  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 -2.0 -3.0  

Profitability 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 158.5% 168.6% 161.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -57.2% -81.0% -89.0%  
ROI %  0.0% 0.0% -67.0% -97.2% -106.8%  
ROE %  0.0% 0.0% -129.9% -130.0% -96.1%  

Solidity 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Equity ratio %  0.0% 0.0% 35.3% -30.3% -18.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 60.8% -36.7% -25.1%  
Gearing %  0.0% 0.0% 141.7% -267.3% -472.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.7% 0.4% 0.2%  

Liquidity 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Quick Ratio  0.0 0.0 6.7 3.6 5.5  
Current Ratio  0.0 0.0 6.7 3.6 5.5  
Cash and cash equivalent  0.0 0.0 33,668.4 15,800.1 23,028.3  

Capital use efficiency 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 33,503.7 16,275.3 23,983.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -2,261 -2,920 -3,044  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -2,261 -2,920 -3,044  
EBIT / employee  0 0 -2,282 -2,941 -3,054  
Net earnings / employee  0 0 -1,826 -2,397 -2,509